cached image

Thomas Ried - Related publications

Cancer Genomics National Cancer Institute, Rockville, MD, United States 
genomic instability and associated gene expression changes during cancer development
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2021 Chen J, Mai H, Chen H, Zhou B, Hou J, Jiang DK. Pan-Cancer Analysis Identified as a Potential Biomarker for Multiple Tumor Types. Frontiers in Molecular Biosciences. 8: 693651. PMID 34490347 DOI: 10.3389/fmolb.2021.693651   
2021 Li W, Song P, Zhao M, Gao L, Xie J, You C. BOP1 Used as a Novel Prognostic Marker and Correlated with Tumor Microenvironment in Pan-Cancer. Journal of Oncology. 2021: 3603030. PMID 34603446 DOI: 10.1155/2021/3603030   
2021 Lawal B, Tseng SH, Olugbodi JO, Iamsaard S, Ilesanmi OB, Mahmoud MH, Ahmed SH, Batiha GE, Wu ATH. Pan-Cancer Analysis of Immune Complement Signature C3/C5/C3AR1/C5AR1 in Association with Tumor Immune Evasion and Therapy Resistance. Cancers. 13. PMID 34439277 DOI: 10.3390/cancers13164124   
2021 Wu SY, Lin KC, Lawal B, Wu ATH, Wu CZ. MXD3 as an onco-immunological biomarker encompassing the tumor microenvironment, disease staging, prognoses, and therapeutic responses in multiple cancer types. Computational and Structural Biotechnology Journal. 19: 4970-4983. PMID 34584637 DOI: 10.1016/j.csbj.2021.08.047   
2021 Chen CL, Meng E, Wu ST, Lai HF, Lu YS, Yang MH, Tsao CW, Kao CC, Chiu YL. Targeting May Result in Enhanced Migration of Cancer Cells in Bladder Carcinoma. Cancers. 13. PMID 34503284 DOI: 10.3390/cancers13174474   
2021 Gu W, Yang J, Wang Y, Xu J, Wang X, Du F, Hu X, Guo H, Song C, Tao R, Zhang X. Comprehensive identification of alterations in 5 557 Chinese patients with solid tumors by next-generation sequencing. American Journal of Cancer Research. 11: 3893-3906. PMID 34522456   
2021 Ahn S, Grimes T, Datta S. The Analysis of Gene Expression Data Incorporating Tumor Purity Information. Frontiers in Genetics. 12: 642759. PMID 34497631 DOI: 10.3389/fgene.2021.642759   
2021 Castro J, Tornillo G, Ceada G, Ramos-Neble B, Bravo M, Ribó M, Vilanova M, Smalley MJ, Benito A. A Nuclear-Directed Ribonuclease Variant Targets Cancer Stem Cells and Inhibits Migration and Invasion of Breast Cancer Cells. Cancers. 13. PMID 34503160 DOI: 10.3390/cancers13174350   
2021 Liu PF, Shu CW, Lee CH, Sie HC, Liou HH, Cheng JT, Ger LP, Chen CL, Chen CC, Chen CF. Clinical Significance and the Role of Guanylate-Binding Protein 5 in Oral Squamous Cell Carcinoma. Cancers. 13. PMID 34439200 DOI: 10.3390/cancers13164043   
2021 Yan Y, Liang Q, Xu Z, Yi Q. Integrative bioinformatics and experimental analysis revealed down-regulated CDC42EP3 as a novel prognostic target for ovarian cancer and its roles in immune infiltration. Peerj. 9: e12171. PMID 34616622 DOI: 10.7717/peerj.12171   
2021 Zboril E, Yoo H, Chen L, Liu Z. Dynamic Interactions of Transcription Factors and Enhancer Reprogramming in Cancer Progression. Frontiers in Oncology. 11: 753051. PMID 34616687 DOI: 10.3389/fonc.2021.753051   
2021 Liu J, Tian Z, Liu T, Wen D, Ma Z, Liu Y, Zhu J. CHSY1 is upregulated and acts as tumor promotor in gastric cancer through regulating cell proliferation, apoptosis, and migration. Cell Cycle (Georgetown, Tex.). 1-14. PMID 34412565 DOI: 10.1080/15384101.2021.1963553   
2021 Cheng L, Creasy T, Pilataxi F, Greenlees L, Vence L, Sridhar S, Streicher K. Effects of combination treatment with durvalumab plus tremelimumab on the tumor microenvironment in non-small-cell lung carcinoma. Cancer Immunology, Immunotherapy : Cii. PMID 34623465 DOI: 10.1007/s00262-021-03065-5   
2021 Kanwore K, Kambey PA, Guo XX, Abiola AA, Xia Y, Gao D. Extracellular and Intracellular Factors in Brain Cancer. Frontiers in Cell and Developmental Biology. 9: 699103. PMID 34513834 DOI: 10.3389/fcell.2021.699103   
2021 Calaf GM, Crispin LA, Roy D, Aguayo F, Muñoz JP, Bleak TC. Gene Signatures Induced by Ionizing Radiation as Prognostic Tools in an In Vitro Experimental Breast Cancer Model. Cancers. 13. PMID 34572798 DOI: 10.3390/cancers13184571   
2021 Lebok P, Schütt K, Kluth M, Witzel I, Wölber L, Paluchowski P, Terracciano L, Wilke C, Heilenkötter U, Müller V, Schmalfeldt B, Simon R, Sauter G, Von Leffern I, Krech T, et al. High mitochondrial content is associated with breast cancer aggressiveness. Molecular and Clinical Oncology. 15: 203. PMID 34462659 DOI: 10.3892/mco.2021.2365   
2021 Ionkina AA, Balderrama-Gutierrez G, Ibanez KJ, Phan SHD, Cortez AN, Mortazavi A, Prescher JA. Transcriptome analysis of heterogeneity in mouse model of metastatic breast cancer. Breast Cancer Research : Bcr. 23: 93. PMID 34579762 DOI: 10.1186/s13058-021-01468-x   
2021 Zhou R, Feng Y, Ye J, Han Z, Liang Y, Chen Q, Xu X, Huang Y, Jia Z, Zhong W. Prediction of Biochemical Recurrence-Free Survival of Prostate Cancer Patients Leveraging Multiple Gene Expression Profiles in Tumor Microenvironment. Frontiers in Oncology. 11: 632571. PMID 34631510 DOI: 10.3389/fonc.2021.632571   
2021 Zhu C, Zhu L, Gu Y, Liu P, Tong X, Wu G, Zhu W, Shen W, Bao H, Ma X, Yu R, Wu X, Zhu D, Shu Y, Feng J. Genomic Profiling Reveals the Molecular Landscape of Gastrointestinal Tract Cancers in Chinese Patients. Frontiers in Genetics. 12: 608742. PMID 34594355 DOI: 10.3389/fgene.2021.608742   
2021 Song L, Qi S, Hu W, Fang Z, Yu D, Liu T, Wu J, Wu Y, Wu A, Feng L, Xie J, Zhang B, He W, Ning Z, Liu L, et al. Integrative analysis reveals clinically relevant molecular fingerprints in pancreatic cancer. Molecular Therapy. Nucleic Acids. 26: 11-21. PMID 34513290 DOI: 10.1016/j.omtn.2021.06.015   
2021 Chen HM, MacDonald JA. Network analysis identifies DAPK3 as a potential biomarker for lymphatic invasion and colon adenocarcinoma prognosis. Iscience. 24: 102831. PMID 34368650 DOI: 10.1016/j.isci.2021.102831   
2021 Sato A, Rahman NIA, Shimizu A, Ogita H. Cell-to-cell contact-mediated regulation of tumor behavior in the tumor microenvironment. Cancer Science. PMID 34420253 DOI: 10.1111/cas.15114   
2021 Lai H, Cheng X, Liu Q, Luo W, Liu M, Zhang M, Miao J, Ji Z, Lin GN, Song W, Zhang L, Bo J, Yang G, Wang J, Gao WQ. Single-cell RNA sequencing reveals the epithelial cell heterogeneity and invasive subpopulation in human bladder cancer. International Journal of Cancer. PMID 34480339 DOI: 10.1002/ijc.33794   
2021 Hua Y, Gao L, Li X. Comprehensive Analysis of Metabolic Genes in Breast Cancer Based on Multi-Omics Data. Pathology Oncology Research : Por. 27: 1609789. PMID 34408553 DOI: 10.3389/pore.2021.1609789   
2021 Li Y, Jin J, Bai F. Cancer biology deciphered by single-cell transcriptomic sequencing. Protein & Cell. PMID 34405376 DOI: 10.1007/s13238-021-00868-1   
2021 Zhao Y, Hu S, Zhang J, Cai Z, Wang S, Liu M, Dai J, Gao Y. Glucoside xylosyltransferase 2 as a diagnostic and prognostic marker in gastric cancer via comprehensive analysis. Bioengineered. 12: 5641-5654. PMID 34506251 DOI: 10.1080/21655979.2021.1967067   
2021 Zhang L, Li Y, Dai Y, Wang D, Wang X, Cao Y, Liu W, Tao Z. Glycolysis-related gene expression profiling serves as a novel prognosis risk predictor for human hepatocellular carcinoma. Scientific Reports. 11: 18875. PMID 34556750 DOI: 10.1038/s41598-021-98381-2   
2021 Bagheri-Yarmand R, Busaidy NL, McBeath E, Danysh BP, Evans KW, Moss TJ, Akcakanat A, Ng PKS, Knippler CM, Golden JA, Williams MD, Multani AS, Cabanillas ME, Shaw KR, Meric-Bernstam F, et al. Alterations Induce Acquired Dabrafenib Resistance in Association with Anaplastic Transformation in a Papillary Thyroid Cancer Patient. Cancers. 13. PMID 34638434 DOI: 10.3390/cancers13194950   
2021 Yoshimatsu Y, Noguchi R, Sin Y, Tsuchiya R, Ono T, Sei A, Sugaya J, Iwata S, Yoshida A, Kawai A, Kondo T. Establishment and characterization of NCC-LGFMS1-C1: a novel patient-derived cell line of low-grade fibromyxoid sarcoma. Human Cell. PMID 34535876 DOI: 10.1007/s13577-021-00612-1   
2021 Lin W, Beasley AB, Ardakani NM, Denisenko E, Calapre L, Jones M, Wood BA, Warburton L, Forrest ARR, Gray ES. Intra- and inter-tumoral heterogeneity of liver metastases in a patient with uveal melanoma revealed by single-cell RNA sequencing. Cold Spring Harbor Molecular Case Studies. PMID 34470851 DOI: 10.1101/mcs.a006111   
2021 Xu Q, Xu H, Chen S, Huang W. Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma. Frontiers in Cell and Developmental Biology. 9: 710207. PMID 34409040 DOI: 10.3389/fcell.2021.710207   
2021 Liu Y, Lou W, Chen G, Ding B, Kuang J, Zhang Y, Wang C, Duan S, Deng Y, Lu X. Genome-wide screening for the G-protein-coupled receptor (GPCR) pathway-related therapeutic gene (regulator of G protein signaling 19) in bladder cancer. Bioengineered. 12: 5892-5903. PMID 34482807 DOI: 10.1080/21655979.2021.1971035   
2021 Cai S, Yao D, Zhang Y, Li Z, Li X, Li L. Cautions should be Taken when Using Cell Models for Gastric Cancer Research. Gene. 145922. PMID 34454032 DOI: 10.1016/j.gene.2021.145922   
2021 Su X, Xu Y, Fox GC, Xiang J, Kwakwa KA, Davis JL, Belle JI, Lee WC, Wong WH, Fontana F, Hernandez-Aya L, Kobayashi T, Tomasson HM, Su J, Bakewell SJ, et al. Breast cancer derived GM-CSF regulates arginase 1 in myeloid cells to promote an immunosuppressive microenvironment. The Journal of Clinical Investigation. PMID 34520398 DOI: 10.1172/JCI145296   
2021 Yim SY, Lee JS. An Overview of the Genomic Characterization of Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. 8: 1077-1088. PMID 34522690 DOI: 10.2147/JHC.S270533   
2021 Hart PC, Bajwa P, Kenny HA. Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity. Advances in Experimental Medicine and Biology. 1330: 75-94. PMID 34339031 DOI: 10.1007/978-3-030-73359-9_5   
2021 Eke I, Aryankalayil MJ, Bylicky MA, Sandfort V, Vanpouille-Box C, Nandagopal S, Graves EE, Giaccia AJ, Coleman CN. Long-term expression changes of immune-related genes in prostate cancer after radiotherapy. Cancer Immunology, Immunotherapy : Cii. PMID 34435232 DOI: 10.1007/s00262-021-03036-w   
2021 Kuzmin E, Monlong J, Martinez C, Kuasne H, Kleinman CL, Ragoussis J, Bourque G, Park M. Inferring Copy Number from Triple-Negative Breast Cancer Patient Derived Xenograft scRNAseq Data Using scCNA. Methods in Molecular Biology (Clifton, N.J.). 2381: 285-303. PMID 34590283 DOI: 10.1007/978-1-0716-1740-3_16   
2021 Prashant NM, Alomran N, Chen Y, Liu H, Bousounis P, Movassagh M, Edwards N, Horvath A. SCReadCounts: estimation of cell-level SNVs expression from scRNA-seq data. Bmc Genomics. 22: 689. PMID 34551708 DOI: 10.1186/s12864-021-07974-8   
2021 Qiao Q, Bai R, Song W, Gao H, Zhang M, Lu J, Hong M, Zhang X, Sun P, Zhang Q, Zhao P. Human α-Defensin 5 suppressed Colon Cancer Growth by Targeting PI3K pathway. Experimental Cell Research. 112809. PMID 34487729 DOI: 10.1016/j.yexcr.2021.112809   
2021 Sakuma S, Raices M, Borlido J, Guglielmi V, Zhu EYS, D'Angelo MA. Inhibition of Nuclear Pore Complex Formation Selectively Induces Cancer Cell Death. Cancer Discovery. 11: 176-193. PMID 32988961 DOI: 10.1158/2159-8290.CD-20-0581   
2021 Zheng M, Hu Y, Gou R, Li S, Nie X, Li X, Lin B. Development of a seven-gene tumor immune microenvironment prognostic signature for high-risk grade III endometrial cancer. Molecular Therapy Oncolytics. 22: 294-306. PMID 34553020 DOI: 10.1016/j.omto.2021.07.002   
2021 Chiu YC, Zheng S, Wang LJ, Iskra BS, Rao MK, Houghton PJ, Huang Y, Chen Y. Predicting and characterizing a cancer dependency map of tumors with deep learning. Science Advances. 7. PMID 34417181 DOI: 10.1126/sciadv.abh1275   
2021 Ku AT, Wilkinson S, Sowalsky AG. Comparison of approaches to transcriptomic analysis in multi-sampled tumors. Briefings in Bioinformatics. PMID 34415294 DOI: 10.1093/bib/bbab337   
2021 Brägelmann J, Lorenz C, Borchmann S, Nishii K, Wegner J, Meder L, Ostendorp J, Ast DF, Heimsoeth A, Nakasuka T, Hirabae A, Okawa S, Dammert MA, Plenker D, Klein S, et al. MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-I. Nature Communications. 12: 5505. PMID 34535668 DOI: 10.1038/s41467-021-25728-8   
2021 Melo CM, Vidotto T, Chaves LP, Lautert-Dutra W, Reis RBD, Squire JA. The Role of Somatic Mutations on the Immune Response of the Tumor Microenvironment in Prostate Cancer. International Journal of Molecular Sciences. 22. PMID 34502458 DOI: 10.3390/ijms22179550   
2021 Wolf SP, Wen FT, Schreiber H. Criteria to make animal studies more relevant to treating human cancer. Current Opinion in Immunology. 74: 25-31. PMID 34619458 DOI: 10.1016/j.coi.2021.09.002   
2021 Zhang H, Kong L, Zhang Y, Wang C, Sun L. Transcriptome and proteome analysis of the antitumor activity of maslinic acid against pancreatic cancer cells. Aging. 13. PMID 34637398 DOI: 10.18632/aging.203623   
2021 Wu R, Shen Q, Li G, Li P, Shang N. The Regulatory Network of Sturgeon Chondroitin Sulfate on Colorectal Cancer Inhibition by Transcriptomic and Proteomic Analysis. International Journal of Molecular Sciences. 22. PMID 34502301 DOI: 10.3390/ijms22179395   
2021 Zhu H, Hu X, Ye Y, Jian Z, Zhong Y, Gu L, Xiong X. Pan-Cancer Analysis of PIMREG as a Biomarker for the Prognostic and Immunological Role. Frontiers in Genetics. 12: 687778. PMID 34594356 DOI: 10.3389/fgene.2021.687778